A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan
3 Year Absolute Returns
71.03% ↑
NAV (₹) on 15 Jun 2026
22.56
1 Day NAV Change
-0.91%
Risk Level
Very High Risk
Rating
-
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan is a Equity mutual fund categorized under Index, offered by Edelweiss Asset Management Ltd.. Launched on 06 Oct 2020, ... Read more
NAV History
Fund Details
Min. SIP Amount
₹100
Inception Date
06 Oct 2020
Min. Lumpsum Amount
₹ 100
Fund Age
5 Yrs
AUM
₹ 178.14 Cr.
Benchmark
Expense Ratio
0.51%
Scheme Type
Open Ended
Exit Load
Nil%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 178.14 Cr
Equity
351.18%
Money Market & Cash
1.1%
Other Assets & Liabilities
147.79%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 54.18% |
| Foreign Securities | 29.04% |
| Hospitals & Medical Services | 16.45% |
| Treps/Reverse Repo | 0.30% |
| Net Receivables/(Payables) | 0.03% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 11.73% | ₹ 19.62 | Pharmaceuticals |
| ELI LILLY & CO | 5.72% | ₹ 9.56 | Others |
| Apollo Hospitals Enterprise Ltd. | 5.59% | ₹ 9.35 | Hospitals & Medical Services |
| Max Healthcare Institute Ltd. | 5.30% | ₹ 8.86 | Hospitals & Medical Services |
| Divi's Laboratories Ltd. | 5.08% | ₹ 8.50 | Pharmaceuticals |
| Cipla Ltd. | 4.84% | ₹ 8.09 | Pharmaceuticals |
| Dr. Reddy's Laboratories Ltd. | 4.76% | ₹ 7.96 | Pharmaceuticals |
| JOHNSON & JOHNSON | 4.52% | ₹ 7.56 | Others |
| Lupin Ltd. | 4.13% | ₹ 6.91 | Pharmaceuticals |
| Torrent Pharmaceuticals Ltd. | 3.55% | ₹ 5.94 | Pharmaceuticals |
| ABBVIE INC | 2.95% | ₹ 4.93 | Others |
| Fortis Healthcare Ltd. | 2.77% | ₹ 4.63 | Hospitals & Medical Services |
| Laurus Labs Ltd. | 2.44% | ₹ 4.08 | Pharmaceuticals |
| Aurobindo Pharma Ltd. | 2.37% | ₹ 3.96 | Pharmaceuticals |
| MERCK & CO.INC | 2.29% | ₹ 3.83 | Others |
| Glenmark Pharmaceuticals Ltd. | 2.27% | ₹ 3.80 | Pharmaceuticals |
| NOVARTIS AG | 2.23% | ₹ 3.73 | Others |
| Alkem Laboratories Ltd. | 1.79% | ₹ 2.99 | Pharmaceuticals |
| Mankind Pharma Ltd. | 1.72% | ₹ 2.88 | Pharmaceuticals |
| Biocon Ltd. | 1.55% | ₹ 2.58 | Pharmaceuticals |
| IPCA Laboratories Ltd. | 1.53% | ₹ 2.57 | Pharmaceuticals |
| AMGEN INC | 1.45% | ₹ 2.43 | Others |
| THERMO FISHER SCIENTIFIC INC | 1.41% | ₹ 2.36 | Others |
| ABBOTT LABORATORIES | 1.36% | ₹ 2.28 | Others |
| GILEAD SCIENCES INC | 1.33% | ₹ 2.22 | Others |
| INTUITIVE SURGICAL INC | 1.26% | ₹ 2.11 | Others |
| Zydus Lifesciences Ltd. | 1.23% | ₹ 2.06 | Pharmaceuticals |
| JB Chemicals & Pharmaceuticals Ltd. | 1.19% | ₹ 1.99 | Pharmaceuticals |
| Aster DM Healthcare Ltd. | 1.05% | ₹ 1.76 | Hospitals & Medical Services |
| DANAHER CORP | 0.93% | ₹ 1.55 | Others |
| Novo Nordisk A/S | 0.91% | ₹ 1.53 | Others |
| Ajanta Pharma Ltd. | 0.89% | ₹ 1.49 | Pharmaceuticals |
| VERTEX PHARMACEUTICALS INC | 0.87% | ₹ 1.45 | Others |
| Gland Pharma Ltd. | 0.87% | ₹ 1.45 | Pharmaceuticals |
| STRYKER CORP | 0.87% | ₹ 1.46 | Others |
| MEDTRONIC PLC | 0.85% | ₹ 1.43 | Others |
| Narayana Hrudayalaya ltd. | 0.82% | ₹ 1.37 | Hospitals & Medical Services |
| GlaxoSmithKline Pharmaceuticals Ltd. | 0.70% | ₹ 1.18 | Pharmaceuticals |
| Regeneron Pharmaceuticals Inc | 0.63% | ₹ 1.05 | Others |
| Global Health Ltd. | 0.55% | ₹ 0.91 | Hospitals & Medical Services |
| BECTON DICKINSON AND CO | 0.34% | ₹ 0.58 | Others |
| Emcure Pharmaceuticals Ltd. | 0.31% | ₹ 0.52 | Pharmaceuticals |
| Clearing Corporation of India Ltd. | 0.26% | ₹ 0.43 | Others |
| AGILENT TECHNOLOGIES INC | 0.25% | ₹ 0.41 | Others |
| Net Receivables/(Payables) | 0.24% | ₹ 0.39 | Others |
| IQVIA HOLDINGS INC | 0.21% | ₹ 0.36 | Others |
| WATERS CORP | 0.09% | ₹ 0.15 | Others |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 10.49% | 12.91% | 11.03% | 19.59% |
| Category returns | 1.65% | 3.23% | 4.76% | 22.27% |
Fund Objective
The Scheme will invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the ... Read more
AMC Details
Name
Edelweiss Asset Management Ltd.
Date of Incorporation
30 Apr 2008
CEO
Mrs. Radhika Gupta
CIO
Mr. Dhawal Dalal, Mr. Trideep Bhattacharya
Type
Pvt.Sector-Indian
Address
Edelweiss House,
Off. C.S.T Road,
Kalina, Mumbai, Maharashtra, India - 400098
Website
http://www.edelweissmf.com
Email
Top Funds from Others - Index Funds/ETFs
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
ICICI Prudential Silver ETF
ETF
Regular
|
₹246.77 | 130.59% | 233.62% | 0.00% | ₹15,986 | 0.40% |
Very High
|
|
Axis Silver ETF
ETF
Regular
|
₹245.50 | 129.68% | 232.82% | 0.00% | ₹2,163 | 0.42% |
Very High
|
|
Kotak Silver ETF
ETF
Regular
|
₹23.98 | 130.14% | 232.68% | 0.00% | ₹3,851 | 0.35% |
Very High
|
|
DSP Silver ETF
ETF
Regular
|
₹238.43 | 130.51% | 232.67% | 0.00% | ₹1,851 | N/A |
Very High
|
|
Mirae Asset Silver ETF
ETF
Regular
|
₹240.44 | 129.68% | 232.09% | 0.00% | ₹1,152 | 0.36% |
Very High
|
|
HDFC Silver ETF
ETF
Regular
|
₹236.37 | 129.21% | 230.92% | 0.00% | ₹8,257 | 0.50% |
Very High
|
|
Aditya Birla Sun Life Silver ETF
ETF
Regular
|
₹246.71 | 130.29% | 230.81% | 0.00% | ₹3,176 | 0.35% |
Very High
|
|
Nippon India Silver ETF
ETF
Regular
|
₹236.41 | 129.64% | 230.75% | 0.00% | ₹32,937 | N/A |
Very High
|
|
UTI Silver Exchange Traded Fund
ETF
Regular
|
₹238.65 | 126.95% | 226.51% | 0.00% | ₹1,480 | 0.59% |
Very High
|
|
Mirae Asset NYSE FANG + ETF
ETF
Regular
|
₹164.04 | 37.32% | 155.58% | 230.11% | ₹4,258 | 0.65% |
Very High
|
Top Funds from Edelweiss Asset Management Ltd.
FAQs
What is the current NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan Growth?
The current Net Asset Value (NAV) of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan Growth is ₹22.56 as of 15 Jun 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan Growth?
The Assets Under Management (AUM) of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan Growth is ₹178.14 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan Growth?
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan Growth has delivered returns of 12.91% (1 Year), 19.59% (3 Year), 12.82% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan Growth?
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan Growth?
The minimum lumpsum investment required for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan Growth is ₹100. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹100, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
What Happens If You Miss Stock Market's Best Days? FundsIndia Reveals Shocking Impact -
Tata Gold ETF: AMC Limits Direct Subscriptions And Lumpsum Inflows From June 8 -
Your Portfolio Can Pay You Every Single Month -
Good Returns: Everyone Wants The “Latest Launch”. But Does That Always Mean Better Value? -
What Is Short Duration Mutual Fund? How it Works? Top 5 Mutual Funds That Delivered Strong Returns -
Unclaimed financial assets portal launched to help Indians trace deposits, insurance, shares -
Why Staying Invested In SIPs For 10 Years Can Greatly Reduce Your Chances Of Losing Money? -
Best Mutual Funds In 2026: Top 5 Infrastructure Funds That Delivered Up To 29% Returns In 3 Years -
AMFI April Data Highlights: Equity Inflows Dip 5% MoM, SIP Contributions Slow Down -
Best Mutual Funds in India: Top 5 Mid Cap Mutual Funds With More than 20% Returns in 5 Yrs
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+